Alzheimer’s Research Update

Mar 01 - 2016 03:52 AM
Alzheimer’s is at the forefront of brain research; 90% of what we know about Alzheimer’s has been discovered in the last 15 years. But while research has discovered much about this devastating disease, there is still much we don’t know.
Read more

Singapore's TauRx mulls Nasdaq IPO and sees a future for Alzheimer's treatment 

Jan 07 - 2016 04:03 AM
Singapore-based TauRx is expected to complete global Phase III trials this year for its Alzheimer's candidate, tau aggregation inhibitor LMTX, that will either start a new chapter in treatment or join a long list of flops.
Read more

Scots dementia drug could delay disease by 15 years

May 05 - 2015 03:00 PM
A DRUG said to halt the onset of Alzheimer’s disease could be on the market in two years after a promising performance in clinical trials.
Read more

Aberdeen scientists developing Alzheimer's drug that could transform the lives of sufferers

May 03 - 2015 03:05 PM
A drug being developed in Aberdeen could transform the lives of millions of Alzheimer’s sufferers.
Read more

Treatment to target tangles

Mar 01 - 2015 02:58 PM
SINGAPORE—Tangles of neuronal fibers are correlated with abnormalities in brain scans of patients with Alzheimer’s disease (AD), but nobody has an approved treatment to target the tangles at the moment, according to Dr. Claude Wischik, co-founder of TauRx Therapeutics Ltd.
Read more